268 Development of FT825/ONO-8250: an off-the-shelf CAR-T cell with preferential HER2 targeting and engineered to enable multi-antigen targeting, improve trafficking, and overcome immunosuppression

• Tom Lee,
• Martin Hosking,
• Yijia Pan,
• Shohreh Sikaroodi,
• Lauren Fong,
• Bahram Valamehr,
• Soheila Shirinbak,
• Angela Gentile,
• Samad Ibitokou,
• Susumu Yamamoto,
• Eigen Peralta,
• Lorraine Loter,
• Laura Chow,
• Peter Szabo,
• Xu Yuan,
• Nicholas Brookhouser,
• Raedun Clarke,
• Kyla Omilusik,
• Shilpi Chandra,
• Stephanie Kennedy,
• Chris Ecker,
• Loraine Campanati,
• Karina Palomares,
• Mika K Kaneko,
• Tatsuo Maeda,
• Daisuke Nakayama,
• Betsy Rezner,
• Ramzey Abujarour,
• Yukinari Kato

Affiliations

Tom Lee

1Fate Therapeutics, Inc., San Diego, CA, USA

Martin Hosking

1Fate Therapeutics, Inc., San Diego, CA, USA

Yijia Pan

1Fate Therapeutics, Inc., San Diego, CA, USA

Shohreh Sikaroodi

1Fate Therapeutics, Inc., San Diego, CA, USA

Lauren Fong

1Fate Therapeutics, Inc., San Diego, CA, USA

Bahram Valamehr

1Fate Therapeutics, Inc., San Diego, CA, USA

Soheila Shirinbak

1Fate Therapeutics, Inc., San Diego, CA, USA

Angela Gentile

1Fate Therapeutics, Inc., San Diego, CA, USA

Samad Ibitokou

Poseida, San Diego, CA, USA

Susumu Yamamoto

3 ONO Pharmaceutical co., ltd., Mishima-Gun, Osaka, Japan

Eigen Peralta

1Fate Therapeutics, Inc., San Diego, CA, USA

Lorraine Loter

1Fate Therapeutics, Inc., San Diego, CA, USA

Laura Chow

1Fate Therapeutics, Inc., San Diego, CA, USA

Peter Szabo

1Fate Therapeutics, Inc., San Diego, CA, USA

Xu Yuan

1Fate Therapeutics, Inc., San Diego, CA, USA

Nicholas Brookhouser

1Fate Therapeutics, Inc., San Diego, CA, USA

Raedun Clarke

1Fate Therapeutics, Inc., San Diego, CA, USA

Kyla Omilusik

1Fate Therapeutics, Inc., San Diego, CA, USA

Shilpi Chandra

1Fate Therapeutics, Inc., San Diego, CA, USA

Stephanie Kennedy

1Fate Therapeutics, Inc., San Diego, CA, USA

Chris Ecker

1Fate Therapeutics, Inc., San Diego, CA, USA

Loraine Campanati

1Fate Therapeutics, Inc., San Diego, CA, USA

Karina Palomares

1Fate Therapeutics, Inc., San Diego, CA, USA

Mika K Kaneko

2 Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

Tatsuo Maeda

3 ONO Pharmaceutical co., ltd., Mishima-Gun, Osaka, Japan

Daisuke Nakayama

3 ONO Pharmaceutical co., ltd., Mishima-Gun, Osaka, Japan

Betsy Rezner

1Fate Therapeutics, Inc., San Diego, CA, USA

Ramzey Abujarour

1Fate Therapeutics, Inc., San Diego, CA, USA

Yukinari Kato

4 Toyoku University, Sendai, Japan